Longitudinal urgency outcomes following robotic-assisted laparoscopic prostatectomy.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 13 02 2023
accepted: 25 05 2023
medline: 19 7 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Stress urinary incontinence (SUI) is a well-known adverse outcome following robotic-assisted laparoscopic prostatectomy (RALP). Although postoperative SUI has been extensively studied, little focus has been placed on understanding the natural history and impact of urgency symptoms following RALP. The UVA prostatectomy functional outcomes program (PFOP) was developed to comprehensively assess and optimize continence outcomes following RALP. The present study focuses on assessing urgency outcomes in this cohort. PFOP patients with a minimum of 6-months follow up following RALP were included. The PFOP includes prospectively assessed incontinence and quality of life outcomes utilizing ICIQ-MLUTS, Urgency Perception Score (UPS), and IIQ-7 questionnaires. The primary study outcome was urgency urinary incontinence (UUI) as determined by ICIQ-MLUTS UUI domain. Secondary outcomes included urgency (UPS score) and quality of life (IIQ-7). Forty patients were included with median age 63.5 years. Fourteen (35%) patients reported UUI at baseline. UUI and QOL scores worsened compared to baseline at all time-points. Urgency worsened at 3-weeks and 3-months but returned to baseline by 6-months. Notably, 63% of patients without baseline UUI reported de-novo UUI at 6 months. Although QOL was lower in patients with versus without UUI (IIQ-7 score 3.0 vs 0.0, p = 0.009), severity of UUI was not associated with QOL when controlling for SUI severity. Our data demonstrate significantly worsened UUI from baseline and a large incidence of de-novo UUI following RALP. Further study is needed to inform how urgency and UUI and its treatment affect health-related quality of life following RALP.

Identifiants

pubmed: 37296234
doi: 10.1007/s00345-023-04458-0
pii: 10.1007/s00345-023-04458-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1885-1889

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Bauer RM et al (2011) Contemporary management of postprostatectomy incontinence. Eur Urol 59(6):985–996. https://doi.org/10.1016/j.eururo.2011.03.020
doi: 10.1016/j.eururo.2011.03.020 pubmed: 21458914
Stanford JL et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer the prostate cancer outcomes study. https://jamanetwork.com/
Hoyland K, Vasdev N (2014) Post–radical prostatectomy incontinence: etiology and prevention. ChM (Urol) 16(4):181–188. https://doi.org/10.3909/riu0606
doi: 10.3909/riu0606
Thiruchelvam N, Cruz F, Kirby M, Tubaro A, Chapple CR, Sievert KD (2015) A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment. BJU Int 116(6):853–861. https://doi.org/10.1111/bju.13078
doi: 10.1111/bju.13078 pubmed: 25684118
Das AK, Kucherov V, Glick L and Chung P (2020) Male urinary incontinence after prostate disease treatment
Agarwal A et al (2014) What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol 65(6):1211–1217. https://doi.org/10.1016/j.eururo.2014.01.019
doi: 10.1016/j.eururo.2014.01.019 pubmed: 24486308 pmcid: 4018666
Abrams P, Avery K, Gardener N, Donovan J (2006) The international consultation on incontinence modular questionnaire: www.iciq.net. J Urol 175(3):1063–1066. https://doi.org/10.1016/S0022-5347(05)00348-4
doi: 10.1016/S0022-5347(05)00348-4 pubmed: 16469618
Cardozo L, Coyne KS, Versi E (2005) Validation of the urgency perception scale. BJU Int 95(4):591–596. https://doi.org/10.1111/j.1464-410X.2005.05345.x
doi: 10.1111/j.1464-410X.2005.05345.x pubmed: 15705086
Rosen R, Cappelleri J, Smith M, Lipsky J, Peña B (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11(6):319–326. https://doi.org/10.1038/sj.ijir.3900472
doi: 10.1038/sj.ijir.3900472 pubmed: 10637462
Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res 3(5):291–306. https://doi.org/10.1007/BF00451721
doi: 10.1007/BF00451721 pubmed: 7841963
Hosier GW, Tennankore KK, Himmelman JG, Gajewski J, Cox AR (2016) Overactive bladder and storage lower urinary tract symptoms following radical prostatectomy. Urology 94:193–197. https://doi.org/10.1016/j.urology.2016.05.007
doi: 10.1016/j.urology.2016.05.007 pubmed: 27181241
Matsukawa Y et al (2018) De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy. Neurourol Urodyn 37(6):2008–2014. https://doi.org/10.1002/nau.23556
doi: 10.1002/nau.23556 pubmed: 29635709
Kan KM, Tin AL, Stearns GL, Eastham JA, Sjoberg DD, Sandhu JS (2022) De novo urinary storage symptoms are common after radical prostatectomy: incidence, natural history and predictors. J Urol 207(3):601–608. https://doi.org/10.1097/JU.0000000000002312
doi: 10.1097/JU.0000000000002312 pubmed: 34694923
Ventimiglia B, Tsirgiotis A, Panzone I, Coco T, Privitera S (2011) Urinary incontinence after radical prostatectomy. Neurophysiological and urodynamic diagnosis. Urologia Journal 78(2):82–85. https://doi.org/10.5301/RU.2011.7975
doi: 10.5301/RU.2011.7975 pubmed: 21553387
Giannantoni A et al (2008) Bladder and urethral sphincter function after radical retropubic prostatectomy: a prospective long-term study. Eur Urol 54(3):657–664. https://doi.org/10.1016/j.eururo.2007.10.054
doi: 10.1016/j.eururo.2007.10.054 pubmed: 18006215
Leach GE, Trockman B, Wong A, Hamilton J, Haab F, Zimmern PE (1996) Post-prostatectomy incontinence: urodynamic findings and treatment outcomes. J Urol 155(4):1256–1259. https://doi.org/10.1016/S0022-5347(01)66235-9
doi: 10.1016/S0022-5347(01)66235-9 pubmed: 8632545
Jung SY et al (1999) Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol 162(1):204–212. https://doi.org/10.1097/00005392-199907000-00069
doi: 10.1097/00005392-199907000-00069 pubmed: 10379788
Castellani D et al (2022) Change in postoperative storage symptoms and de novo urge incontinence after Thulium: YAG laser enucleation of the prostate: results from a prospective multicenter study. J Endourol. https://doi.org/10.1089/end.2022.0118
doi: 10.1089/end.2022.0118 pubmed: 35972727
Cho MC et al (2011) Predictor of de novo urinary incontinence following holmium laser enucleation of the prostate. Neurourol Urodyn. https://doi.org/10.1002/nau.21050
doi: 10.1002/nau.21050 pubmed: 21826726
Coyne KS et al (2009) The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS

Auteurs

Emmett H Kennady (EH)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA.

Jacqueline Zillioux (J)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA.

Marwan Ali (M)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA.

Dylan Hutchison (D)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA.

Jacques Farhi (J)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA.

Anthony DeNovio (A)

University of Virginia School of Medicine, Charlottesville, VA, USA.

David Barquin (D)

University of Virginia School of Medicine, Charlottesville, VA, USA.

David E Rapp (DE)

Department of Urology, University of Virginia, UVA Medical Center, 500 Ray C. Hunt Drive, Charlottesville, VA, USA. Der4m@virginia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH